Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How does leukemia invade the central nervous system?

C Pochedly

    Postgraduate Medicine
    |January 1, 1976
    PubMed
    Summary

    Systemic therapy prolongs survival in childhood acute leukemia, but increases central nervous system (CNS) leukemia. Leukemic cells in the CNS often originate from bone marrow or lymph nodes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Introduction.

    Pediatric annals·2014
    Same author

    Introduction.

    Pediatric annals·2014
    Same author

    Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia.

    Medical and pediatric oncology·1991
    Same author

    Prevention of meningeal leukemia. Review of 20 years of research and current recommendations.

    Hematology/oncology clinics of North America·1990
    Same author

    Meningeal leukemia: current concepts in biology and treatment. Introduction.

    The American journal of pediatric hematology/oncology·1989
    Same author

    Ethical dilemmas: the dark side of medical progress.

    Pediatric annals·1988

    Area of Science:

    • Hematology
    • Pediatric Oncology
    • Neuro-oncology

    Background:

    • Systemic therapy has improved survival rates for children with acute leukemia.
    • This has led to a concerning increase in the incidence of central nervous system (CNS) leukemia.
    • CNS leukemia presents unique challenges in diagnosis and treatment.

    Purpose of the Study:

    • To investigate the origins of leukemic cell infiltration in the central nervous system.
    • To understand the relationship between systemic therapy, survival, and CNS leukemia development.
    • To provide insights into the metastatic pathways of acute leukemia.

    Main Methods:

    • Review of existing evidence on CNS leukemia in acute leukemia patients.
    • Analysis of data from animal models (mice) inoculated with leukemia cells.
    • Correlation of chemotherapy regimens with the incidence of CNS involvement.

    Main Results:

    • Prolongation of survival in acute leukemia patients treated with systemic therapy is associated with a higher incidence of CNS leukemia.
    • In experimental models, CNS infiltrates were infrequent unless survival was extended by chemotherapy.
    • Evidence suggests that leukemic cells in the CNS predominantly originate from the bone marrow or lymph nodes.

    Conclusions:

    • The increased incidence of CNS leukemia is a consequence of improved survival due to systemic therapy.
    • Understanding the primary sites of leukemic cell origin (bone marrow, lymph nodes) is crucial for developing targeted CNS-directed therapies.
    • Further research is needed to elucidate the mechanisms of CNS dissemination and to improve prevention and treatment strategies for CNS leukemia.

    Related Experiment Videos